¼¼°èÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå
Blood Gas and Electrolyte Analyzers
»óǰÄÚµå : 1766920
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 459 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 12¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 8¾ï 9,510¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 5.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 12¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÈÞ´ë¿ëÀº CAGR 6.0%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 8¾ï 2,360¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º¥Ä¡Å¾ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 5,670¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº 2024³â¿¡ 2¾ï 5,670¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï 4,550¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.3%¿Í 4.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â´Â Çö´ë ÀÇ·á Áø´Ü¿¡ ÇʼöÀûÀÎ µµ±¸·Î ȯÀÚÀÇ È£Èí, ´ë»ç, ÀüÇØÁú »óÅ¿¡ ´ëÇÑ Áß¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ÀåÄ¡´Â pH, »ê¼ÒºÐ¾Ð(pHO2), ÀÌ»êȭź¼ÒºÐ¾Ð(pCO2), Áßź»ê¿°(HCO3-), ³ªÆ®·ý(Na+), Ä®·ý(K+), Ä®½·(Ca2+), ¿°È­¹°(Cl-), Á¥»ê¿°°ú °°Àº ÀüÇØÁúÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÆÄ¶ó¹ÌÅ͸¦ ÃøÁ¤ÇÕ´Ï´Ù. Ç÷¾× »ùÇÃÀ» ºÐ¼®ÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡´Â ȯÀÚÀÇ »ê-¿°±â ÆòÇü, »ê¼ÒÈ­ ¼öÁØ ¹× Àü¹ÝÀûÀÎ ÀüÇØÁú ±ÕÇüÀ» Æò°¡ÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ´Ù¾çÇÑ Áúº´À» Áø´ÜÇÏ°í °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. È£ÈíºÎÀü, ´ë»ç¼º »êÁõ ¶Ç´Â ¾ËÄ®¸®Áõ, ½ÅÀå ±â´É Àå¾Ö, ÀüÇØÁú ºÒ±ÕÇü°ú °°Àº º´Å´ ÀÌ·¯ÇÑ ºÐ¼®±â¸¦ »ç¿ëÇÏ¿© ÁÖÀÇ ±í°Ô ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç(ICU), ¼ö¼ú½Ç, ½Å»ý¾Æ½Ç µî ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ ÇʼöÀûÀ̸ç, ½Å¼ÓÇϰí Á¤È®ÇÑ °Ë»ç °á°ú´Â Àû½Ã¿¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÇÑ ÀÓ»óÀû ÆÇ´ÜÀ» ³»¸®´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â¸¦ µÞ¹ÞħÇÏ´Â ±â¼úÀº Á¤È®¼º, È¿À²¼º ¹× »ç¿ë ÆíÀǼºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÃֽŠºÐ¼®±â¿¡´Â ÷´Ü ¼¾¼­¿Í ÀÚµ¿È­ ½Ã½ºÅÛÀÌ ³»ÀåµÇ¾î ÀÖ¾î °Ë»ç ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­Çϰí, ÀÎÀû ¿À·ùÀÇ À§ÇèÀ» ÁÙÀ̸ç, ÀϰüµÇ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü¿¡´Â ¹Ì¼¼ Àü±Ø ±â¼úÀÇ »ç¿ëµµ Æ÷ÇԵ˴ϴÙ. ¸¶ÀÌÅ©·Î Àü±Ø ±â¼úÀº ¸Å¿ì ÀûÀº ¾çÀÇ Ç÷¾× »ùÇÿ¡¼­ Ç÷¾×°¡½º ¹× ÀüÇØÁú ¼öÄ¡¸¦ Á¤È®ÇÏ°Ô ÃøÁ¤ÇÒ ¼ö ÀÖ¾î ¼Ò¾Æ ¹× ½Å»ý¾Æ ÀÇ·á¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ÃÖ±Ù ¸¹Àº ±â±âµéÀº ȯÀÚÀÇ Ä§´ë ¿·¿¡¼­ Áï½Ã ºÐ¼®ÇÒ ¼ö ÀÖ´Â ÇöÀå °Ë»ç ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÈÞ´ë¿ë ºÐ¼®±â´Â ´Ü½Ã°£¿¡ °á°ú¸¦ ¾òÀ» ¼ö ÀÖµµ·Ï ¼³°èµÇ¾úÀ¸¸ç, Á¾Á¾ ¸î ºÐ ¾È¿¡ °á°ú°¡ ³ª¿À±â ¶§¹®¿¡ ½Å¼ÓÇÑ ÀÇ·á °³ÀÔÀÌ °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ, ¹«¼± µ¥ÀÌÅÍ Àü¼Û ¹× ÀüÀÚ ÀÇ·á ±â·Ï(EMR) ½Ã½ºÅÛ°úÀÇ È£È¯¼º°ú °°Àº ¿¬°á ±â´ÉÀÇ ÅëÇÕÀ¸·Î ÀÇ·á ½Ã¼³ÀÇ ¿öÅ©Ç÷ο찡 °³¼±µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¿øÈ°ÇÑ µ¥ÀÌÅÍ °ü¸® ¹× °øÀ¯ ±â´ÉÀ» ÅëÇØ ÀÇ·á Àü¹®°¡µéÀÌ È¯ÀÚ µ¥ÀÌÅÍ¿¡ È¿À²ÀûÀ¸·Î Á¢±ÙÇϰí Ȱ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾î, ´õ ³ªÀº Áø·á Çù·Â°ú ȯÀÚ °á°ú °³¼±À¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î °íÁ¤¹Ð ±â±â °³¹ß°ú °°Àº ±â¼úÀû Áøº¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ºÐ¼® ±â±âÀÇ ¿ëµµ°¡ ±âÁ¸ °Ë»ç½Ç ȯ°æ¿¡¼­ ÇöÀå Áø·á ȯ°æÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ±¸±ÞÂ÷, ¿ø°ÝÁø·á¼Ò, ½ÉÁö¾î ȯÀÚÀÇ Áý µî ´Ù¾çÇÑ È¯°æ¿¡¼­ Áß¿äÇÑ Áø´Ü °Ë»ç¸¦ ¼öÇà ÇÒ ¼öÀÖ°ÔÇÏ¿© ÀÇ·áÀÇ ¹üÀ§¿Í ¿µÇâÀ» È®´ëÇß½À´Ï´Ù. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ´ç´¢º´, ½ÅÀåÁúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ È®»êÀÌ ÁøÇàµÊ¿¡ µû¶ó Ç÷¾×°¡½º ¹× ÀüÇØÁú ¼öÁØÀÇ ºó¹øÇϰí Á¤È®ÇÑ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸¸¼ºÁúȯÀº Áö¼ÓÀûÀÎ °ü¸®¿Í ¸é¹ÐÇÑ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü µµ±¸ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¸¼ºÁúȯ ¹× °ü·Ã ÇÕº´Áõ¿¡ Ãë¾àÇÑ ¼¼°è Àα¸ÀÇ °í·ÉÈ­´Â ÀÌ·¯ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó Ä¡·áÇÏ´Â ¸ÂÃãÇü ÀÇ·á Æ®·»µå¿Í Á¶±â Áø´Ü ¹× ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½Éµµ ½ÃÀå ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â´Â Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Æò°¡¸¦ °¡´ÉÇÏ°Ô Çϸç, °³Àκ° ¸ÂÃã Ä¡·á °èȹ°ú ¿¹¹æ Á¶Ä¡¿¡ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. À̵é Áö¿ªÀÇ Á¤ºÎ¿Í ¹Î°£ ºÎ¹®Àº Áõ°¡ÇÏ´Â Àα¸ÀÇ ÀÇ·á ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ Çö´ë½Ä ÀÇ·á ½Ã¼³°ú Áø´Ü Àåºñ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÇ·áÀÇ Áú°ú Á¢±Ù¼º Çâ»óÀ» À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê´Â ÀÇ·áºñ Áõ°¡¿Í ÇÔ²² ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±âÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇÏ¿© ´õ ¸¹Àº ȯÀÚµéÀÌ Àû½Ã¿¡ Á¤È®ÇÑ Áø´Ü ¼­ºñ½ºÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖµµ·Ï ÇÒ °ÍÀÔ´Ï´Ù.

ºÎ¹®

¸ð´Þ¸®Æ¼(ÈÞ´ë¿ë, º¥Ä¡Å¾), Á¦Ç°(º¹ÇÕ ºÐ¼®±â, ÀüÇØÁú ºÐ¼®±â, Ç÷¾×°¡½º ºÐ¼®±â), ÃÖÁ¾»ç¿ë(ÀÓ»ó °Ë»ç½Ç, POC(Point of Care))

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Blood Gas and Electrolyte Analyzers Market to Reach US$1.2 Billion by 2030

The global market for Blood Gas and Electrolyte Analyzers estimated at US$895.1 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$823.6 Million by the end of the analysis period. Growth in the Benchtop segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$256.7 Million While China is Forecast to Grow at 6.7% CAGR

The Blood Gas and Electrolyte Analyzers market in the U.S. is estimated at US$256.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$145.5 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Blood Gas and Electrolyte Analyzers Market - Key Trends & Drivers Summarized

Blood gas and electrolyte analyzers are essential tools in modern medical diagnostics, providing critical information about a patient’s respiratory, metabolic, and electrolyte status. These devices measure a range of parameters, including pH, partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), bicarbonate (HCO3-), and electrolytes such as sodium (Na+), potassium (K+), calcium (Ca2+), chloride (Cl-), and lactate. By analyzing blood samples, healthcare professionals can assess the acid-base balance, oxygenation levels, and overall electrolyte balance in patients, which is crucial for diagnosing and managing a variety of medical conditions. Conditions such as respiratory failure, metabolic acidosis or alkalosis, renal dysfunction, and electrolyte imbalances are closely monitored using these analyzers. These devices are indispensable in various healthcare settings, including emergency departments, intensive care units (ICUs), operating rooms, and neonatal units, where rapid and accurate test results are essential for making timely and informed clinical decisions.

The technology behind blood gas and electrolyte analyzers has advanced significantly, enhancing their accuracy, efficiency, and ease of use. Modern analyzers incorporate sophisticated sensors and automated systems that streamline the testing process, reduce the risk of human error, and ensure consistent and reliable results. These advancements include the use of microelectrode technology, which allows for precise measurements of blood gas and electrolyte levels from very small blood samples, making the analyzers particularly useful in pediatric and neonatal care. Many contemporary devices offer point-of-care testing capabilities, enabling immediate analysis at the patient's bedside, which is especially beneficial in critical care situations where time is of the essence. These portable analyzers are designed to provide quick turnaround times, often delivering results within minutes, thereby enabling prompt medical intervention. Additionally, the integration of connectivity features, such as wireless data transfer and compatibility with electronic medical records (EMR) systems, has improved the workflow in healthcare facilities. This seamless data management and sharing capability ensures that healthcare professionals can access and utilize patient data efficiently, leading to better coordination of care and improved patient outcomes.

The growth in the blood gas and electrolyte analyzer market is driven by several factors. Technological advancements, such as the development of portable, user-friendly, and highly accurate devices, have broadened the application of these analyzers beyond traditional laboratory settings to include point-of-care environments. This shift has made it possible to perform critical diagnostic tests in a variety of settings, including ambulances, remote clinics, and even patients' homes, thus enhancing the reach and impact of medical care. The increasing prevalence of chronic diseases, such as chronic obstructive pulmonary disease (COPD), diabetes, and kidney disorders, has heightened the demand for frequent and accurate monitoring of blood gas and electrolyte levels. These chronic conditions often require ongoing management and close monitoring, which in turn drives the need for reliable diagnostic tools. Additionally, the aging global population, which is more susceptible to chronic diseases and related complications, has further contributed to the rising demand for these diagnostic tools. The trend towards personalized medicine, where treatments are tailored to individual patient needs, and the emphasis on early diagnosis and preventive care also play a crucial role in market growth. Blood gas and electrolyte analyzers enable precise and timely assessments that inform individualized treatment plans and preventive measures. Governments and private sectors in these regions are investing in modern healthcare facilities and diagnostic equipment to meet the growing healthcare needs of their populations. Government initiatives aimed at improving healthcare quality and accessibility, coupled with increasing healthcare expenditure, further propel the adoption of blood gas and electrolyte analyzers across various healthcare settings, ensuring that more patients benefit from timely and accurate diagnostic services.

SCOPE OF STUDY:

The report analyzes the Blood Gas and Electrolyte Analyzers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Portable, Benchtop); Product (Combined Analyzers, Electrolyte Analyzers, Blood Gas Analyzers); End-Use (Clinical Laboratories, Point of Care)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 53 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â